Acadian Asset Management’s ALX Oncology ALXO Stock Holding History

Acadian Asset Management’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.2M	Sell	1,101,025 -273,248	-20%	-$521K	﹤0.01%	926
2025 Q4	$1.55M	Buy	1,374,273 +153,448	+13%	+$232K	﹤0.01%	984
2025 Q3	$2.23M	Sell	1,220,825 -47,174	-4%	-$40.9K	﹤0.01%	866
2025 Q2	$525K	Sell	1,267,999 -28,332	-2%	-$14.3K	﹤0.01%	1126
2025 Q1	$806K	Buy	1,296,331 +186,883	+17%	+$224K	﹤0.01%	981
2024 Q4	$1.85M	Buy	1,109,448 +683,024	+160%	+$1.05M	0.01%	783
2024 Q3	$773K	Buy	+426,424	New	+$1.59M	﹤0.01%	981
2022 Q3	–	Sell	-20,955	Closed	-$170K	–	1662
2022 Q2	$170K	Buy	+20,955	New	+$228K	﹤0.01%	1236

Other funds holding ALXO

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Acadian Asset Management's ALXO Position: Q1 2026 in Review

Acadian Asset Management reduced its ALX Oncology (ALXO) stake by 20% in Q1 2026, selling an estimated $521K and leaving 1,101,025 shares worth $2.2M. The position accounts for ﹤0.01% of the portfolio, ranked #926.

Acadian Asset Management first reported a position in ALXO in Q2 2022 and has held it in 8 quarters since. The position peaked at $2.23M in Q3 2025. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

Acadian Asset Management held 1,101,025 shares of ALX Oncology worth $2.2M as of Q1 2026.
Acadian Asset Management sold 273,248 ALX Oncology shares in Q1 2026, an estimated $521K.
ALX Oncology made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #926 holding.
Acadian Asset Management first reported a position in ALX Oncology in Q2 2022 and has held it in 8 quarters since.
Acadian Asset Management's ALX Oncology position peaked at $2.23M in Q3 2025.
69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.